Botulinum toxin A modulates afferent fibers in neurogenic detrusor overactivity

European Journal of Neurology

Volumn 19, Issue 5, 2012, Pages 725-732

  Conte, A ^a,b   Giannantoni, A ^c   Proietti, S ^c   Giovannozzi, S ^c   Fabbrini, G ^b   Rossi, A ^c   Porena, M ^c   Berardelli, A ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS NEUROMED   (Italy)

^c UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Bladder afferents; Botulinum toxin A; Parkinson's disease; Spinal cord injury

Indexed keywords

BOTULINUM TOXIN A; LEVODOPA;

ADULT; AGED; ARTICLE; BLADDER FILLING; BLADDER INNERVATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOMETRY; DETRUSOR MUSCLE; DRUG MECHANISM; FEMALE; HOFFMANN REFLEX; HUMAN; MALE; NERVE FIBER C; NEUROGENIC BLADDER; NEUROMODULATION; NEUROTRANSMISSION; OVERACTIVE BLADDER; PARKINSON DISEASE; PRIORITY JOURNAL; SENSORY NERVE; SPINAL CORD INJURY; TREATMENT OUTCOME; URODYNAMICS;

ADULT; AFFERENT PATHWAYS; AGED; ANALYSIS OF VARIANCE; BOTULINUM TOXINS, TYPE A; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; H-REFLEX; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; PAIN MEASUREMENT; PARKINSON DISEASE; SPINAL CORD INJURIES; STATISTICS AS TOPIC; ULTRASONOGRAPHY, DOPPLER; URINARY BLADDER, OVERACTIVE; URODYNAMICS;

EID: 84859873402     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03618.x     Document Type: Article

References (28)

1. Apostolidis A, Dasgupta P, Denys P, et al. Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus report. Eur Urol 2009; 55: 100-119.
2. Giannantoni A, Rossi A, Mearini E, et al. Botulinum toxin A for overactive bladder and detrusor muscle overactivity in patients with Parkinson's disease and multiple system atrophy. J Urol 2009; 182: 1453-1457.
3. Giannantoni A, Conte A, Proietti S, et al. Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder. J Urol 2011; 186: 960-964.
4. Kulaksizoglu H, Parman Y. Use of botulinum toxin-A for the treatment of overactive bladder symptoms in patients with Parkinson's disease. Parkinsonism Relat Disord 2010; 16: 531-534.
5. Abbruzzese G, Berardelli A. Neurophysiological effects of botulinum toxin type A. Neurotox Res 2006; 9: 109-114.
6. Stöhrer M, Schurch B, Kramer G, et al. Botulinum A-toxin in the treatment of detrusor hyperreflexia in spinal cord injured patients: a new alterantive to medical and surgical procedures?. Neurourol Urodyn 1999; 18: 401-402.
7. Apostolidis A, Dasgupta P, Fowler CJ. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity. Eur Urol 2006; 49: 644-650.
8. Giannantoni A, Di StasiSM, Nardicchi V, et al. Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. J Urol 2006; 175: 2341-2344.
9. Inghilleri M, Carbone A, Pedace F, et al. Bladder filling inhibits somatic spinal motoneurones. Clin Neurophysiol 2001; 112: 2255-2260.
10. Carbone A, Palleschi G, Parascani R, et al. Modulation of viscero-somatic H-reflex during bladder filling: a possible tool in the differential diagnosis of neurogenic voiding dysfunctions. Eur Urol 2002; 42: 281-288.
11. Mai J, Pedersen E. Central effect of bladder filling and voiding. J Neurol Neurosurg Psychiatry 1976; 39: 171-177.
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-184.
13. Wagner TH, Patrick DL, Bavendam TG, et al. Quality of life of persons with urinary incontinence: development of a new measure. Urology 1996; 47: 67-71.
14. Lukacz ES, Whitcomb EL, Lawrence JM, et al. Are sexual activity and satisfaction affected by pelvic floor disorders? Analysis of a community-based survey Am J Obstet Gynecol 2007; 197: 88.
15. Stöhrer M, Goepel M, Kondo A, et al. The standardization of terminology in neurogenic lower urinary tract dysfunction: with suggestions for diagnostic procedures. International Continence Society Standardization Committee. Neurourol Urodyn 1999; 18: 139-158.
16. Knikou M, Rymer Z. Effects of changes in hip joint angle on H-reflex excitability in humans. Exp Brain Res 2002; 143: 149-159.
17. Chen CY, Liao CH, Kuo HC. Therapeutic effects of detrusor botulinum toxin A injection on neurogenic detrusor overactivity in patients with different levels of spinal cord injury and types of detrusor sphincter dyssynergia. Spinal Cord 2011; 49: 659-664.
18. Brin MF. Development of future indications for BOTOX. Toxicon 2009; 54: 668-674.
19. Flynn MK, Amundsen CL, Perevich M, et al. Outcome of a randomized, double-blind, placebo controlled trial of botulinum A toxin for refractory overactive bladder. J Urol 2009; 181: 2608-2615.
20. Munoz A, Somogyi GT, Boone TB, Smith CP. Central inhibitory effect of intravesically applied botulinum toxin A in chronic spinal cord injury. Neurourol Urodyn 2011; 30: 1376-1381.
21. de Groat WC. Anatomy and physiology of the lower urinary tract. Urol Clin North Am 1993; 20: 383-401.
22. Yoshimura N. Bladder afferent pathway and spinal cord injury: possible mechanisms inducing hyperreflexia of the urinary bladder. Prog Neurobiol 1999; 57: 583-606.
23. Cheng CL, de Groat WC. The role of capsaicin-sensitive afferent fibers in the lower urinary tract dysfunction induced by chronic spinal cord injury in rats. Exp Neurol 2004; 187: 445-454.
24. de Groat WC, Kawatani M, Hisamitsu T, et al. Mechanisms underlying the recovery of urinary bladder function following spinal cord injury. J Auton Nerv Syst 1990; 30(Suppl): S71-S77.
25. Chuang YC, Yoshimura N, Huang CC, et al. Intravesical botulinum toxin a administration produces analgesia against acetic acid induced bladder pain responses in rats. J Urol 2004; 172: 1529-1532.
26. Porter RW, Krell M. Alterations in the H-reflex in the paraplegic induced by bladder distension. Paraplegia 1976; 14: 105-114.
27. Jankowska E, Hammar I. Spinal interneurones; how can studies in animals contribute to the understanding of spinal interneuronal systems in man? Brain Res Brain Res Rev 2002; 40: 19-28.
28. Crone C, Johnsen LL, Biering-Sorensen F, Nielsen JB. Appearance of reciprocal facilitation of ankle extensors from ankle flexors in patients with stroke or spinal cord injury. Brain 2006; 126: 495-507.